For instance, De Ciuceis et al. [191] compared the effects of exenatide and liraglutide, showing that only the first one was able to increase EPCs numbers (CD34+ KDR+) in T2DM patients after 4 and 7 weeks of treatment. Here, CD34 is linked to type 2 diabetes mellitus.